• Barriers and enablers to reclassification in Germany | |
• Experiences of the processes and committee meetings | |
• Potential improvements to the process or constitution of the committee | |
• Quality of applications | |
• Views on reclassification and self-medication generally | |
• The ability of pharmacy to manage non-prescription medicines | |
• Access to doctors in Germany | |
• Consumer culture and behaviour | |
• Research on reclassifications | |
• Market exclusivity related to collection of evidence | |
• Potential areas for reclassification. |